Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study-Reference-Cited by-同舟云学术

Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study

Published:2015-04 Issue:4 Volume:16 Page:395-405
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Melichar Bohuslav,Adenis Antoine,Lockhart A Craig,Bennouna Jaafar,Dees E Claire,Kayaleh Omar,Obermannova Radka,DeMichele Angela,Zatloukal Petr,Zhang Bin,Ullmann Claudio Dansky,Schusterbauer Claudia

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Aurora kinases;Bolanos-Garcia;Int J Biochem Cell Biol,2005

2. Aurora A kinase (AURKA) in normal and pathological cell division;Nikonova;Cell Mol Life Sci,2013

3. A novel aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma;Gorgun;Blood,2010

4. Frequent overexpression of aurora kinase A in upper gastrointestinal adenocarcinomas correlates with potent antiapoptotic functions;Dar;Cancer,2008

5. Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast;Hoque;Cancer Epidemiol Biomarkers Prev,2003

Cited by 208 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Aurora Kinase A Inhibition Potentiates Platinum and Radiation Cytotoxicity in Non-Small-Cell Lung Cancer Cells and Induces Expression of Alternative Immune Checkpoints;Cancers;2024-08-09

2. Small cell lung cancer: emerging subtypes, signaling pathways, and therapeutic vulnerabilities;Experimental Hematology & Oncology;2024-08-05

3. BRCA1 orchestrates the response to BI-2536 and its combination with alisertib in MYC-driven small cell lung cancer;Cell Death & Disease;2024-07-31

4. Bioprinting native-like 3D micro breast cancer tissues utilizing existing cancer cell lines;International Journal of Bioprinting;2024-06-13

5. Knowledge mapping of AURKA in Oncology：An advanced Bibliometric analysis (1998–2023);Heliyon;2024-06